|
 |
|
|||||||
|
|||||||||
Diabetes 52:2854-2860, 2003
© 2003 by the American Diabetes Association, Inc.
Permanent Neonatal Diabetes Caused by Glucokinase Deficiency
Inborn Error of the Glucose-Insulin Signaling Pathway
1 Department of Pediatrics, Haukeland University Hospital, University of Bergen, Norway
2 Center for Medical Genetics and Molecular Medicine, Haukeland University Hospital, University of Bergen, Norway
3 Department of Biochemistry and Biophysics, and Diabetes Research Center, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania
4 Department of Pediatrics, Rambam Medical Center, Haifa, Israel
5 Division of Newborn Medicine, Department of Pediatrics, Gülhane Military Medical Academy, Ankara, Turkey
6 Department of Pathology, the Gade Institute, Haukeland University Hospital, University of Bergen, Norway
Neonatal diabetes can be either permanent or transient. We have recently shown that permanent neonatal diabetes can result from complete deficiency of glucokinase activity. Here we report three new cases of glucokinase-related permanent neonatal diabetes. The probands had intrauterine growth retardation (birth weight <1,900 g) and insulin-treated diabetes from birth (diagnosis within the first week of life). One of the subjects was homozygous for the missense mutation Ala378Val (A378V), which is an inactivating mutation with an activity index of only 0.2% of wild-type glucokinase activity. The second subject was homozygous for a mutation in the splice donor site of exon 8 (intervening sequence 8 [IVS8] + 2T
G), which is predicted to lead to the synthesis of an inactive protein. The third subject (second cousin of subject 2) was a compound heterozygote with one allele having the splice-site mutation IVS8 + 2TG and the other the missense mutation Gly264Ser (G264S), a mutation with an activity index of 86% of normal activity. The five subjects with permanent neonatal diabetes due to glucokinase deficiency identified to date are characterized by intrauterine growth retardation, permanent insulin-requiring diabetes from the first day of life, and hyperglycemia in both parents. Autosomal recessive inheritance and enzyme deficiency are features typical for an inborn error of metabolism, which occurred in the glucose-insulin signaling pathway in these subjects.
Address correspondence and reprint requests to Pål R. Njølstad, MD, PhD, Department of Pediatrics, University of Bergen, N-5021 Bergen, Norway. E-mail: pal.njolstad{at}uib.no
CiteULike 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  L. Bjorkhaug, J. Molnes, O. Sovik, P. R. Njolstad, and T. Flatmark Allosteric Activation of Human Glucokinase by Free Polyubiquitin Chains and Its Ubiquitin-dependent Cotranslational Proteasomal Degradation J. Biol. Chem., August 3, 2007; 282(31): 22757 - 22764. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. L. Sorenson, L. E. Stout, T. C. Brelje, T. L. Jetton, and F. M. Matschinsky Immunohistochemical Evidence for the Presence of Glucokinase in the Gonadotropes and Thyrotropes of the Anterior Pituitary Gland of Rat and Monkey J. Histochem. Cytochem., June 1, 2007; 55(6): 555 - 566. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. S. Slingerland and A. T. Hattersley Activating Mutations in the Gene Encoding Kir6.2 Alter Fetal and Postnatal Growth and Also Cause Neonatal Diabetes J. Clin. Endocrinol. Metab., July 1, 2006; 91(7): 2782 - 2788. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. V. Sagen, S. Odili, L. Bjorkhaug, D. Zelent, C. Buettger, J. Kwagh, C. Stanley, K. Dahl-Jorgensen, C. de Beaufort, G. I. Bell, et al. From Clinicogenetic Studies of Maturity-Onset Diabetes of the Young to Unraveling Complex Mechanisms of Glucokinase Regulation Diabetes, June 1, 2006; 55(6): 1713 - 1722. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J R Porter and T G Barrett Monogenic syndromes of abnormal glucose homeostasis: clinical review and relevance to the understanding of the pathology of insulin resistance and {beta} cell failure J. Med. Genet., December 1, 2005; 42(12): 893 - 902. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. C. Koster, M. A. Permutt, and C. G. Nichols Diabetes and Insulin Secretion: The ATP-Sensitive K+ Channel (KATP) Connection Diabetes, November 1, 2005; 54(11): 3065 - 3072. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. T. Hattersley and F. M. Ashcroft Activating Mutations in Kir6.2 and Neonatal Diabetes: New Clinical Syndromes, New Scientific Insights, and New Therapy Diabetes, September 1, 2005; 54(9): 2503 - 2513. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Efanov, D. G. Barrett, M. B. Brenner, S. L. Briggs, A. Delaunois, J. D. Durbin, U. Giese, H. Guo, M. Radloff, G. S. Gil, et al. A Novel Glucokinase Activator Modulates Pancreatic Islet and Hepatocyte Function Endocrinology, September 1, 2005; 146(9): 3696 - 3701. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Meyre, P. Boutin, A. Tounian, M. Deweirder, M. Aout, B. Jouret, B. Heude, J. Weill, M. Tauber, P. Tounian, et al. Is Glutamate Decarboxylase 2 (GAD2) a Genetic Link between Low Birth Weight and Subsequent Development of Obesity in Children? J. Clin. Endocrinol. Metab., April 1, 2005; 90(4): 2384 - 2390. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. N. Weedon, T. M. Frayling, B. Shields, B. Knight, T. Turner, B. S. Metcalf, L. Voss, T. J. Wilkin, A. McCarthy, Y. Ben-Shlomo, et al. Genetic Regulation of Birth Weight and Fasting Glucose by a Common Polymorphism in the Islet Cell Promoter of the Glucokinase Gene Diabetes, February 1, 2005; 54(2): 576 - 581. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. V. Sagen, H. Raeder, E. Hathout, N. Shehadeh, K. Gudmundsson, H. Baevre, D. Abuelo, C. Phornphutkul, J. Molnes, G. I. Bell, et al. Permanent Neonatal Diabetes due to Mutations in KCNJ11 Encoding Kir6.2: Patient Characteristics and Initial Response to Sulfonylurea Therapy Diabetes, October 1, 2004; 53(10): 2713 - 2718. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Vaxillaire, C. Populaire, K. Busiah, H. Cave, A. L. Gloyn, A. T. Hattersley, P. Czernichow, P. Froguel, and M. Polak Kir6.2 Mutations Are a Common Cause of Permanent Neonatal Diabetes in a Large Cohort of French Patients Diabetes, October 1, 2004; 53(10): 2719 - 2722. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Inoue, Y. Sakuraba, H. Motegi, N. Kubota, H. Toki, J. Matsui, Y. Toyoda, I. Miwa, Y. Terauchi, T. Kadowaki, et al. A series of maturity onset diabetes of the young, type 2 (MODY2) mouse models generated by a large-scale ENU mutagenesis program Hum. Mol. Genet., June 1, 2004; 13(11): 1147 - 1157. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. L. Gloyn, E. R. Pearson, J. F. Antcliff, P. Proks, G. J. Bruining, A. S. Slingerland, N. Howard, S. Srinivasan, J. M.C.L. Silva, J. Molnes, et al. Activating Mutations in the Gene Encoding the ATP-Sensitive Potassium-Channel Subunit Kir6.2 and Permanent Neonatal Diabetes N. Engl. J. Med., April 29, 2004; 350(18): 1838 - 1849. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Diabetes | Diabetes Care | Clinical Diabetes | Diabetes Spectrum |